cytarabine has been researched along with Atypical Chronic Myeloid Leukemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boissel, N; Cluzeau, T; Devillier, R; Dombret, H; Kiladjian, JJ; Lengline, E; Raffoux, E; Rey, J; Robin, M; Ronchetti, AM; Sebert, M; Vey, N | 1 |
| Borthakur, G; Champlin, RE; Cortes, JE; Daver, N; Garcia-Manero, G; Issa, GC; Jabbour, E; Jain, N; Kadia, TM; Kantarjian, HM; Kebriaei, P; Khouri, I; Konopleva, M; O'Brien, SM; Pierce, S; Qiao, W; Ravandi, F; Sasaki, K; Short, NJ; Thomas, D; Yin, CC | 1 |
| Hackanson, B; Lübbert, M; Rückert, A | 1 |
| Bergamaschi, G; Carella, AM; Cazzola, M; Ferrero, R; Podestá, M; Pollicardo, N; Pungolino, E; Raffo, MR; Rosti, V; Saglio, G | 1 |
| Bernasconi, P; Betti, AR; Caricchi, P; Donti, E; Ferrajoli, A; Lazzarino, M; Liberati, AM; Morra, E; Saglio, G | 1 |
| Carella, AM; Celesti, L; Corsetti, MT; Dejana, A; Frassoni, F; Lerma, E; Panagiotis, Z | 1 |
| Hayashi, S; Inatomi, Y; Iwama, H; Katagiri, T; Kawakubo, K; Kuriyama, Y; Miyazawa, K; Nehashi, Y; Ohyashiki, K; Shimamoto, T; Shyohji, N; Toyama, K; Uchida, Y; Yaguchi, M | 1 |
| Ahmed, T; Arlin, ZA; Feldman, EJ; Liebowitz, D; Shapiro, LR; Wilmot, PL | 1 |
1 review(s) available for cytarabine and Atypical Chronic Myeloid Leukemia
| Article | Year |
|---|---|
Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Disease Progression; Fatal Outcome; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Leukocytosis; Male; Monosomy; Philadelphia Chromosome; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Selection, Genetic | 2009 |
1 trial(s) available for cytarabine and Atypical Chronic Myeloid Leukemia
| Article | Year |
|---|---|
Idarubicin-containing regimen and G-CSF are capable of recruiting CD34+/DR- cells with high proliferative potential which sustain Ph-negative polyclonal hematopoiesis.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; HLA-DR Antigens; Humans; Idarubicin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged | 1994 |
6 other study(ies) available for cytarabine and Atypical Chronic Myeloid Leukemia
| Article | Year |
|---|---|
Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Feasibility Studies; Female; Humans; Idarubicin; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged; Nitriles; Pyrazoles; Pyrimidines; Treatment Outcome | 2016 |
Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cytarabine; Cytodiagnosis; Disease-Free Survival; Doxorubicin; Female; Humans; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Treatment Outcome; Vincristine | 2017 |
Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patients.
Topics: Adult; Aged; Combined Modality Therapy; Cytarabine; Female; Humans; Interferon Type I; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged; Pilot Projects; Polymerase Chain Reaction; Recombinant Proteins; Remission Induction | 1995 |
Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Idarubicin; Leukapheresis; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged; Pilot Projects | 1998 |
[Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Clone Cells; Cytarabine; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged; Survivors | 1998 |
Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALL.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Middle Aged; Potassium Chloride; Remission Induction; Time Factors | 1989 |